Treatment options for inflammatory bowel disease (IBD) have advanced significantly over the past few decades, particularly with the introduction of biologic therapies starting in 1998. Biologics like infliximab (Remicade®), adalimumab (Humira®), vedolizumab (Entyvio®), and ustekinumab (...

Whether you currently take medication for inflammatory bowel disease (IBD) or you’re facing a recent diagnosis, you have several treatment options such as biologic therapies which are made with biological material and include biosimilars. Biosimilars are medications that are designed ...

Have you received a notification from your insurance carrier that coverage of your specialty medication is changing? If so, you aren’t the only one. Many of my patients who are on biologics have been informed by their insurer that they are now required to switch to a biosimilar. I know ...

When biosimilars first entered the market five years ago, I was excited about new treatment options for patients and for more competition to be created in the market. In the years since, we have seen seven biosimilars approved by the U.S. Food & Drug Administration for IBD indicatio...